Pathology note 8 BLEEDING DISORDER

Similar documents
HEME 10 Bleeding Disorders

Coagulation Disorders. Dr. Muhammad Shamim Assistant Professor, BMU

Bleeding and Thrombotic Disorders. Kristine Krafts, M.D.

Congenital bleeding disorders

Dr. Rai Muhammad Asghar Associate Professor Head of Pediatric Department Rawalpindi Medical College

Dr. MUBARAK ABDELRAHMAN MD PEDIATRICS AND CHILD HEALTH Assistant Professor FACULTY OF MEDICINE -JAZAN

LAMA SHATAT TTP, ITP, DIC

Bleeding Disorders. Dr. Mazen Fawzi Done by Saja M. Al-Neaumy Noor A Mohammad Noor A Joseph Joseph

Haemostasis & Coagulation disorders Objectives:

ACQUIRED COAGULATION ABNORMALITIES

Bleeding Disorders: (Hemorrhagic Diatheses) Tests used to evaluate different aspects of hemostasis are the following:

Thrombotic Thrombocytopenic Purpura and the Role of ADAMTS-13

UNIT VI. Chapter 37: Platelets Hemostasis and Blood Coagulation Presented by Dr. Diksha Yadav. Copyright 2011 by Saunders, an imprint of Elsevier Inc.

This slide belongs to iron lecture and it is to clarify the iron cycle in the body and the effect of hypoxia on erythropoitein secretion

Platelet Disorders. By : Saja Al-Oran

Bleeding Disorders HOPE Maram Al-anbar

Hemostatic System - general information

Moath Darweesh. Omar Sami. Saleem Khreisha. 1 P a g e

Heme (Bleeding and Coagulopathies) in the ICU

Bleeding disorders. Hemostatic failure: Inappropriate and excessive bleeding either spontaneous or in response to injury.

PCCN Review Hematology

Primary Exam Physiology lecture 5. Haemostasis

Document Title: Hemostasis: Platelet and Coagulation Disorders. Author(s): Joseph H. Hartmann (University of Michigan), DO 2012

Haemorrhagic Disorders. Dr. Bashar Department of Pathology Mosul Medical College

Hemostasis. Learning objectives Dr. Mária Dux. Components: blood vessel wall thrombocytes (platelets) plasma proteins

Chapter 19. Hemostasis

Topics of today lectures: Hemostasis

Some renal vascular disorders

Bleeding Disorders.2 MS Abdallah Awidi Abbadi.MD. FRCP.FRCPath Feras Fararjeh MD

Coagulation an Overview Dr.Abdolreza Abdolr Afrasiabi Thal assem a & Heamophili hilia G ene i tic R esearc C en er Shiraz Medical Medic University

Disseminated Intravascular Coagulation. M.Bahmanpour MD Assistant professor IUMS

Thrombosis and emboli. Peter Nagy

What is meant by Thrombotic Microangiopathy (TMA)?

INHERITED COAGULOPATHY

Anatomy and Physiology

What are blood clots?

Schematic Of Heparin Induced Thrombocytopenia Platelet Count

THROMBOTIC MICROANGIOPATHY. Jun-Ki Park 7/19/11

Ch. 45 Blood Plasma proteins, Coagulation and Fibrinolysis Student Learning Outcomes: Describe basic components of plasma

Effective Date: Approved by: Laboratory Director, Jerry Barker (electronic signature)

Blood Lecture Test Questions Set 2 Summer 2012

Non-immune acquired haemolytic anaemias. Dr.Maysem

The LaboratoryMatters

There are two main causes of a low platelet count

EDUCATIONAL COMMENTARY PLATELET DISORDERS

Extra Notes 3. Warm. In the core (center) of the body, where the temperature is 37 C.

Approach to bleeding disorders &treatment. by RAJESH.N General medicine post graduate

Approach To A Bleeding Patient

The Child with a Hematologic Alteration

* Renal insufficiencies

Physiology of. The Blood hemostasis. By prof. Israa f. jaafar

Blood coagulation and fibrinolysis. Blood clotting (HAP unit 5 th )

Easy Bleeding General Presentation

BLEEDING (PLATELET) DISORDER. IAP UG Teaching slides

DIC. Bert Vandewiele Fellow Critical Care 23 May 2011

Hemostasis. Clo)ng factors and Coagula4on NORMAL COAGULATION. Overview of blood coagula4on. The Cascade Theory 5/1/12. Clot

John Davidson Consultant in Intensive Care Medicine Freeman Hospital, Newcastle upon Tyne

Hematologic changes in systemic diseases. Chittima Sirijerachai

Y. Helen Zhang, MD Andy Nguyen, MD 10/28/2012

Platelet vs. Coagulation Bleeding. Qualitative and Quantitative Platelet Disorders. Laboratory Tests. Platelet Signaling. Jeffrey S. Jhang, M.D.

Oral Anticoagulant Drugs

PHM142 Lecture 4: Platelets + Endothelial Cells

Hemodynamic Disorders, Thrombosis, and Shock. Richard A. McPherson, M.D.

Chapter 14. Blood. Blood Volume. Blood Composition. Blood

The importance of thrombocytopenia and its causes

Thrombotic thrombocytopenic purpura: a look at the future

A 60 year old woman with altered mental status and thrombotic microangiopathy. Josh Veatch

Things to never miss in the office. Brett Houston MD FRCPC (PYG-5, hematology) Leonard Minuk MD FRCPC

New insights in thrombotic microangiopathies : TTP and ahus

Bleeding and Haemostasis. Saman W.Boskani HDD, FIBMS Maxillofacial Surgeon

Hematologic Disorders. Assistant professor of anesthesia

BLEEDING DISORDERS Simple complement:

Sysmex Educational Enhancement and Development No

COAGULATIONS. Dr. Hasan Fahmawi, MRCP(UK), FRCP(Edin)

11. An acute leukemia causing. 12. An adult patient presents with acute. 13. Anemia due to renal failure may be

R. Coward has documented that he has received cooperative grants from Takeda and Novo Nordisk

Hemostasis and thrombosis in patients with liver disease. Ton Lisman, Dept Surgery, UMC Groningen, The Netherlands

Approccio morfologico alle microangiopatie trombotiche

Acute Immune Thrombocytopenic Purpura (ITP) in Childhood

Let`s go for the diagnosis! Yazeed Toukan, MD Pediatric Pulmonary Institute, Ruth Rappaport Children`s Hospital July 2016

Chapter 06 Lecture Outline. See separate PowerPoint slides for all figures and tables preinserted into PowerPoint without notes.

HAEMORRHAGIA Bleeding

-Hashim ahmed is the one who wrote this sheet. I just edited it according to our record.

WBCs production(leucopoiesis):

Hemolytic uremic syndrome: Investigations and management

DISSEMINATED INTRAVASCULAR COAGULATION (DIC) Pichika Chantrathammachart MD Division of Hematology, Department of Medicine Ramathibodi Hospital

3 Ruba hussein Dr. ahmad Dr. ahmad

Blood Transfusion Guidelines in Clinical Practice

Step 2. Common Blood Tests, and the Coulter Counter Readout

Chapter 19 Blood Lecture Outline

Hemostasis Haemostasis means prevention of blood loss from blood vessels.

TTP, Sickle Cell Disease, and the role of von Willebrand factor

Average adult = 8-10 pints of blood. Functions:

Hemostasis Haemostasis means prevention of blood loss from blood vessels.

Hemostasis. PHYSIOLOGICAL BLOOD CLOTTING IN RESPONSE TO INJURY OR LEAK no disclosures

Most Common Hemostasis Consults: Thrombocytopenia

Disseminated Intravascular Coagulation (DIC) Seminar. Ron Kopilov 4 th year Medical Student, Tel Aviv University Internal Medicine A 8.3.

Agent Dose MoA/PK/Admin Adverse events Disadvantages Protamine Heparin: 1mg neutralizes ~ 100 units Heparin neutralization in ~ 5 min

Branch of medicine that deals with blood, its formation and disorders is called. Three main functions of cardiovascular system are,, and.

PLASMA EXCHANGE J MANION NEPEAN HOSPITAL

Transcription:

Pathology note 8 BLEEDING DISORDER Slide75 ( Types of clotting factors deficiency): Today we will talk about public public factor deficiency it could be acquired or inherited, acquired diseases are more common and multiple factor deficiency. The most common causes are : 1- Chronic liver diseases The site of synthesis over 10 factors 2- Vitamin K deficiency From its name K from coagulation, and this vitamin Is Important for the function of factors X,IX,VII and II (1972). these factors are depend on vitamin K and if it is absent, they will not work so patient will have bleeding. The same principle is Warfarin drug it is inhibit factors that depend on vitamin K so in over dose Warfarin cause bleeding by this mechanism. 3- Disseminated intravascular coagulation We will talk about it at the end of the lecture. In this disease there will be a consumption of all clotting factors, so the patient will end up with bleeding.

4- Autoimmune diseases Antibodies are formed against clotting factors. We finished talking about acquired causes of bleeding disorders and we will talk about inhireted causes Slide 76 ( Hemophilia A): It is an X-linked disease so it is more common in boys. Factor VIII is a cofactor for factor IX and factor IX activates factor X, so there is a deficiency in intrinsic pathway. Internal pathway is abnormal so there is a coinfection in PTT ( PTT is abnormal). This family history in 70 % of cases from mother and the patient have hemophilia. In 30 % it is a new mutation starts with person who pass it to the next generation. the level of factor VIII must be decrease to less than 1%to be a spontaneous bleeding, this is a severe case it has only 1% of normal level. most cases are milder they have a little amount help in, milder they have multiple mutation ( the more the amount will loss, the severity will increase ).

In milder cases patients behave well until predisposing factors that activates the internal pathway so patients develop bleeding. 90% of cases there are a true deficiency, there is a low level of factor VIII. 10% the level is normal but the function is abnormal. Slide 77 ( Clinical features ): Always clotting factors appear deep seetled area in the body not in skin. Usually skin bleeding is controlled by platelets, small capillaries of skin need these platelets to be blunt to close ( no deep seeted here). Easily bruising specially in boys after circumcision there will be a prolong bleeding. The most common site of bleeding is skeletal system : joints and muscles so frequently patients have bone pain. Petechia differentiate clotting factor deficiency bleeding from platelets deficiency bleeding. Develop anemia as a result of blood loss. Slide 78 (Tests) : Patient with PTT may be inherited or may be acquired. Mixing study to differentiate between acquired and inherited.

In mixing study we get a normal serum with all clotting factors and we mix it with patient blood and we measure PTT again, so deficiency should be corrected because we mix patient serum with clotting factor VIII. So normal cell PTT normalized if it does not, that means the patient has auto antibodies against new factor VIII.(acquired has auto antibodies) PTT: partial thromboplastic type is measure the intrinsic pathway. Extrinsic has another pathway it is PT. Bleeding time third test measure the function of platelets ( separate and know where is the defect exactly). PTT PT Bleeding time intrinsic extrinsic platelets Slide 79 (Hemophilia B ) : Same hemophilia A in abnormality and symptoms. Factor VIII is already a cofactor for IX if this one is absent,any one is absent so will develop the symptom. It is correctable by mixing study. Slide 80 and 81(Von Willibrand disease ): It is more common than hemophilia.

AD so affect both gender. vwf normally circulates in blood carries factor VIII to protect it from degradation by enzyme. they do not work until there is a stripping to endothelium (endothelial injury ) so the cell expose to the below the endothelium. the environment is very thrombogenic to plug the damage usually by trauma. once epithelium is stripped the collagen is exposed or vwf attach to the collagen, once it is attached it attached platelets, platelets have receptor for glycoprotein 1 b that bind vwf. once it is bound the platelets start to adhere to each other with help of other factors and fibrinogen so it forms hemostatic plug. Hemostatic plug the first step of thrombosis. Hemostatic is a primary coagulation stage and it is platelets attached to vwf. In vwf deficiency no platelets adhesion and there is a permanent of bleeding. Slide 82 (vwf deficiency ): Type 1 : multiquantitive true deficiency. Type 2: abnormal protein ( abnormal shape ).as a result of mutation this abnormal one has activity does not need collagen so the enzyme decrease this abnormal protein and causes deficiency.

Type 2 from type 1 that 2 has platelets deficiency ( thrombocytopenia that causes bleeding ). Bleeding in both types as a result of no adhesion of platelets. Secondery factor VIII deficiency as a result of factor VIII cleavage by the enzyme so they are not protected. Bleeding more pronounced in deep area. VWF usually milder than hemophilia. PTT is prolonged as a result of lost factor VIII Anemia because of blood loss. Secondary hemophilia. Low platelets. We finished clotting factors deficiency disorders. Let s go to platelets disorders. Slide 84 (ITP) : Immune mediated so it is acquired. Antibodies bind normal platelets. Autoantibody IgG binds platelets proteins GP IIb/IIIa a normal protein important in platelets adherence. Patients will have thrombocytopenia. Ig s are synthesized in spleen cell. itself it is not known well now but patients with splenectomy have correction of disease. ( removing spleen is treatment )

Acute: after cold and flu may the child has bleeding,we test the platelets which they are low (thrombocytopenia) Chronic :- common as a part of autoimmune disease RBC s are normal Common in middle aged female ( usually autoimmune disease more common in woman ). Correction by splenectomy. Only platelets are low then they are immature and they are larger than ordinary platelets. BM: normal hematopoisis( like in hemolytic anemia ) Skin bleeding is common also they have deep organs bleeding. There is a bleeding in critical organ like brain that kills patient. Slide 85 (TTP): Immature platelets ( it is big when it released then it will be damaged ). Thrombopoietin increases production. Totally different disease Part of microangiopathic hemolytic anemia. Clinically (5 symptoms ): Fever Anemia (hemolytic, schestocytes)

Thrombocytopenia Neuroligic symptoms Renal failure Renal failure is more prominent in hemolytic syndrome than in TTP. uremic Neurological symptoms more obviously in TTP than in hemolytic uremic syndrome. Slide 86 ( pathogenesis ) : VWF normally has a big precursor. Deficiency with ADAMTS 13 ends up with big number of multimers. In normal situation these multimers do not prolong because they are a potent aggregator of platelets (acts by itself without any activation ). In deficiency activemultimer causes platelates aggregation everywhere so thrombosis are found all over the body in this disease. Causes of ADAMTS 13 deficiency either inherited (less common ) or acquired ( more common ). In acquired cases autoantibodies are formed against the ADAMTS enzyme the multimer activates and the platelets aggregates and thrombosis everywhere in body. PT and PTT are normal.

Thrombocytopenia because the consumption of platelets in thrombosis which formed everywhere. Bleeding time is prolonge. Slide 87 (DIC) : Systemic activation of clotting factor (activation everywhere in the body as a result of different factors ). Next stage anticlotting factor start to work remove thrombi that are formed everywhere end up with bleeding and no platelets different factor activates tissue factors that activate coagulation cascade this one release in high amount certain situation like in : 1-sepsis (septicemia ): bacteria release entrotropin which activate monocyte that release tissue factors in high amount in the body so it is end with DIC. 2- circulation activates thrombosis. myiosin in cancer cells when they do invasion and open circulation sometimes malignant cell lysis release myosin that trigger coagulation cascade end up with DIC. 3- in delivery sometimes complication make to death as a result of DIC. 4 in head trauma(brain ) part of the tissue released in circulation and activate the cascade. Slide 89 ( pathogenesis ):

Second mechanism there is a wide spread endothelial damage in the body following different situation. Snake venom does wide spread endothelial damage that lead to systemic lupus erythematosis (SLE) In some autoimmune disease like SLE autoantibodies are deposited in blood and cause endothelia damage. In general all microangiopathic disease are emergency patients can bleed to death in few moments there is no thing to prevent or stop the bleeding in the body. thrombocytopenia in peripheral blood most important in microangiopahic PT and PTT are normal in TTP while they are prolong in DIC. Sorry for any mistake Shaima Al-Haj